Literature DB >> 3022260

Characteristics of the beta-adrenergic stimulation of adenylate cyclase activity in rat ventral prostate and its modulation by androgens.

P Poyet, B Gagne, F Labrie.   

Abstract

Beta-adrenergic agents cause a 2.5-3-fold stimulation of adenylate cyclase activity in rat ventral prostate membrane preparations with an order of potency (KD values) typical of a beta 2-subtype receptor: (-)isoproterenol (20 nM) greater than (-)epinephrine (70 nM) much greater than (-)norepinephrine (1 microM) much greater than dopamine (70 microM). The stimulatory effect exerted by high concentrations of dopamine (greater than 0.1 mM) is completely reversed by propranolol but not by haloperidol or sulpiride, thus indicating an action of dopamine mediated by the beta-adrenergic receptor. One week after castration, basal adenylate cyclase activity in prostatic membranes is 50% reduced. In the same group, the stimulation by isoproterenol is completely abolished in the absence of GTP, while the effect of GTP alone is reduced by 75%. The inhibitory effect of castration on basal as well as isoproterenol- and GTP-stimulated adenylate cyclase activity can be completely reversed by treatment of castrated animals with dihydrotestosterone, thus demonstrating the marked androgen dependency of adenylate cyclase activity in prostatic tissue. Since the response to direct stimulation of adenylate cyclase activity (assessed by NaF and forskolin) is only reduced by 33%-60% while the response to isoproterenol is 100% abolished, the present data indicates that the complete loss of beta-adrenergic responsiveness of prostatic adenylate cyclase following castration includes many steps, including those preceding adenylate cyclase activity, namely the beta-adrenergic receptor itself and/or its coupling via the GTP-binding protein. The large amplitude of the effects observed should facilitate study of the mechanisms involved in the marked regulation of the beta-adrenergic receptor-adenylate cyclase system by androgens in prostatic tissue.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3022260     DOI: 10.1002/pros.2990090304

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  5 in total

1.  Functional beta-adrenergic receptors in breast cancer cells.

Authors:  B Vandewalle; F Revillion; J Lefebvre
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Beta-adrenergic receptors in DMBA-induced rat mammary tumors: correlation with progesterone receptor and tumor growth.

Authors:  B Marchetti; P G Spinola; M Plante; P Poyet; N Folléa; G Pelletier; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1989-07       Impact factor: 4.872

3.  Behavioral stress accelerates prostate cancer development in mice.

Authors:  Sazzad Hassan; Yelena Karpova; Daniele Baiz; Dana Yancey; Ashok Pullikuth; Anabel Flores; Thomas Register; J Mark Cline; Ralph D'Agostino; Nika Danial; Sandeep Robert Datta; George Kulik
Journal:  J Clin Invest       Date:  2013-01-25       Impact factor: 14.808

4.  Post-natal development modulates the rat seminal vesicle sensitivity to sympathomimetic agonists.

Authors:  R D Soares; M L de Abreu; C S Porto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-07       Impact factor: 3.000

Review 5.  Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate.

Authors:  Martin C Michel; Wim Vrydag
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.